Estimation and comparison of thrombocyte count by peripheral blood smear method and automated method in women with pregnancy
Keywords:Automatic hematology analyzer, Peripheral blood smear, Thrombocyte count
Background: Thrombocyte is important and very essential component of blood and have significant role in maintenance of hemostasis. Thrombocyte count is an important investigation done in various acquired and congenital coagulable states which include conditions like pregnancy. Thrombocyte count is routinely done by automated hematology analyzer method. The automated hematology analyzer counters are not usually available at all centres especially in peripheral and rural side though thrombocytes can also be assessed from the peripheral blood smears, which can be easily and precisely done at any set up. Aim and objective of this study was to compare the thrombocyte estimation by peripheral blood smear method and automated hematology analyzer in pregnant women.
Methods: Thrombocyte estimation was done from samples taken from 120 normal pregnant women between December 2018 to March 2019, where samples were Ethylene Diamine Tetra Acetic acid (EDTA) anticoagulated. Thrombocyte was counted manually using PBS (Leishman stain) and hematology analyzer (Sysmex XN1000 series). Thrombocyte counts were expressed in Mean and standard Deviation. Statistical analysis was done by student’s t test using MS excel and SPSS version 17.
Results: Thrombocyte count by PBS have mean value of 2.04 lacs/mm3 with standard deviation of 0.56 lacs/mm3 and by automated method have mean value of 1.89 lacs/mm3 and standard deviation of 0.71 lacs/mm3 with p value 0.010. Thus, there was no statistically significant difference found between two methods.
Conclusions: Estimation of thrombocyte count on the basis of manual thrombocyte count is a reliable technique and can be used to validate automated thrombocyte counts. It can also be used in under resourced laboratories, where there are no automated counters of good precision available. In fact, all the tests showing abnormal thrombocyte counts must be reported only after cross examining on PBS.
Hartwing HJ. Platelet morphology. In: Loscalzo J, Schafer IA, editors. Thrombosis and Haemorrhage. 2nd Ed. Blatimore: Williams & Wilkins; 1998:207.
Firkin F, Chesterman C, Penington D, Rush B. The haemorrhagic disorders. In: De Gruchy’s Clinical Hematology in Medical Practice. 5th Ed. Oxford: Blackwell Scientific Publications; 1989:375-376.
Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993 Jun 1;81(11):2844-53.
Sibai BM. Hypertension in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, (eds). Obstetrics: Normal and Problem of Pregnancies. 3rd Ed. New York: Churchill Livingstone; 1996:935-991.
Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstom KD. Hypertensive disorders in pregnancy. In: Seilis A, Noujaim SR, Davis K, (eds). Williams Obstetrics. 21st Ed. New York: McGraw Hill; 2001:567-618.
Malok M, Titchener EH, Bridgers C, Lee BY, Bamberg R. Comparison of two thrombocyte count estimation methodologies for peripheral blood smears. Clin Lab Sci. 2007;20(3):154-60.
Webb DI, Parker L, Webb K. Platelet count assessment from peripheral blood smear (PBS). Alaska Med. 2004;46(4):92-5.
Brahimi M, Osmani S, Arabi A, Enta-Soltan B, Taghezout Z, Elkahili BS, et al. The estimation of thrombocyte count from a blood smear on the basis of the red cell: platelet ratio. Turk J Hematol. 2009;26(1):21-4.
Sullivan CA, Martin JN, Jr. Management of the obstetric patient with thrombocytopenia. Clin Obstet Gynecol. 1995;38(3):521-34.
Romero R, Mazor M, Lockwood CJ, Emamian M, Belanger KP, Hobbins JC, et al. Clinical significance, prevalence, and natural history thrombocytopenia in pregnancy-induced hypertension. Am J Perinatol. 1989;6(1):32-8.
Yin SM, Li YQ, Xie SF, Ma LP, Wu YD, Nie DN, et al. Study on the variation of thrombocyte function in pregnancy induced hypertension and gestational diabetes mellitus” Zhonghua Fu Chan Ke Za Zhi. 2005;40(1):25-8.
Anjali SA, Amy S. Platelet Function Disorder. In: Schulman S, editor. Treatment of Haemophilia. 2nd Ed. Wiley-Blackwell: World Federation of Hemophilia; 2008:1-3.